Akari Therapeutics (AKTX) Return on Assets (2015 - 2026)
Akari Therapeutics (AKTX) reported Return on Assets of 0.01% for Q1 2026, little changed on a YoY basis from 0.01% in Q1 2025, and down 79.88% sequentially from 0.0% in Q4 2025.
Akari Therapeutics (AKTX) Return on Assets (2015 - 2026) Analysis & Trends
Akari Therapeutics (AKTX) has 11 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.
- For the quarter ending Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
- Return on Assets retreated to 0.01% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q2 2025 to a low of 0.05% in Q3 2024.
- A 4-year average of 0.02% and a median of 0.01% in 2022 frame the typical range for Return on Assets.
- Across the five-year window, Return on Assets changed 0 bps in 2022 and gained 5 bps in 2025, its largest moves.
- Tracing AKTX's Return on Assets over 4 years: stood at 0.01% in 2022, then sank by 35 bps to 0.01% in 2024, then soared by 47 bps to 0.0% in 2025, then slumped by 80 bps to 0.01% in 2026.
- Business Quant data shows AKTX's Return on Assets at 0.01% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -0.01% |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -0.80% |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 0.00% |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.05% |
| Jun 30, 2024 | -0.05% |
| Mar 31, 2024 | -0.05% |
| Dec 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Dec 31, 2020 | -0.01% |
| Sep 30, 2020 | -0.01% |
| Jun 30, 2020 | -0.02% |
| Mar 31, 2020 | -0.03% |
| Dec 31, 2019 | -0.02% |
| Sep 30, 2019 | -0.01% |
| Jun 30, 2019 | -0.01% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |